Home Data Calendar Blog

XNCR

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Common Stock Value 0.000.000.000.000.000.000.000.000.000.570.570.570.570.560.560.560.560.470.470.470.47
Earnings Per Share Basic -0.55-0.570.401.26-0.690.90-0.04-0.24-0.22-0.61-0.14-0.47-0.18-0.281.42-0.320.06-0.25-0.33-0.15-0.31
Earnings Per Share Diluted -0.55-0.570.391.21-0.690.87-0.04-0.24-0.22-0.61-0.14-0.47-0.18-0.281.38-0.320.05-0.25-0.33-0.15-0.31

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Revenue From Contract With Customer Excluding Assessed Tax 0.030.030.090.150.020.070.030.040.0413.0932.383.5221.7619.48111.9411.5629.0430.150.0012.503.50
Revenues 0.030.030.090.150.020.070.030.040.0413.0932.383.5221.7619.48111.9411.5629.0430.150.0012.503.50
Operating Expenses 0.070.060.060.060.060.060.050.060.0550.6941.1634.0936.0439.0633.7032.6528.3924.8223.5821.0119.86
Research And Development Expense 0.050.050.050.050.050.050.040.050.0443.4633.9427.3429.7733.3028.1827.1320.9520.4019.4116.9215.05
General And Administrative Expense 0.010.010.010.010.010.010.010.010.017.237.226.756.275.765.515.527.434.434.174.094.81
Operating Income Loss -0.04-0.030.030.09-0.040.01-0.02-0.01-0.02-37.60-8.78-30.57-14.28-19.5778.24-21.080.65-13.88-16.49-7.67-15.52
Interest Income Expense Net 0.000.000.000.000.000.000.000.000.002.093.043.423.703.622.892.812.641.051.04NANA
Interest Paid Net 0.000.000.000.000.000.000.000.00-0.010.010.010.000.000.000.000.010.000.010.000.000.00
Income Tax Expense Benefit 0.00NANANANANANANANANANA-0.29-0.350.050.90NANA-1.090.170.280.17
Profit Loss -0.03-0.030.020.07-0.040.05-0.00-0.0143.04-35.02-8.07-26.91-10.22-16.0380.05-18.203.15-11.84-15.56-6.04-15.47
Net Income Loss -0.03-0.030.020.07-0.040.05-0.00-0.01-0.01-35.02-8.07-26.91-10.22-16.0380.05-18.203.15-11.84-15.56-6.88-14.63
Comprehensive Income Net Of Tax -0.03-0.040.020.07-0.040.05-0.00-0.01-0.01-34.59-8.18-27.19-10.42-14.7581.36-16.832.82-12.55-15.42-6.93-14.39
Net Income Loss Available To Common Stockholders Basic -0.03-0.030.020.07-0.040.05-0.00-0.01-0.01-35.02-8.07-26.91-10.22-16.0380.05-18.203.15-3.07-22.65-7.72-15.47

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Assets 0.840.850.860.840.700.700.690.700.65644.72666.96670.25686.24684.75697.00576.73585.59390.10398.25416.16418.30
Liabilities 0.110.110.090.100.080.050.110.130.0874.0873.9677.0576.0176.6687.4455.0553.31108.06107.72114.80114.56
Liabilities And Stockholders Equity 0.840.850.860.840.700.700.690.700.65644.72666.96670.25686.24684.75697.00576.73585.59390.10398.25416.16418.30
Stockholders Equity 0.720.740.760.730.620.650.580.570.57570.64593.00593.20610.24608.09609.57521.68532.27282.05290.54301.37303.75

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Assets Current 0.670.590.510.420.330.480.590.640.57603.39588.11558.40573.76527.01488.67315.73286.92230.88217.81210.98166.09
Cash And Cash Equivalents At Carrying Value 0.050.050.080.140.040.120.180.160.06109.5373.8150.3151.1932.5621.8626.2535.0016.5313.6311.2213.56
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 0.050.050.080.140.040.120.180.160.06109.5373.8150.3151.1932.5621.8626.2535.0016.5313.6311.22NA
Accounts Receivable Net Current 0.040.050.090.070.020.010.010.010.018.936.8321.574.3510.13137.6810.192.461.140.8314.886.94
Prepaid Expense And Other Assets Current 0.020.020.020.020.020.020.010.010.017.406.486.557.5311.319.4310.3812.105.617.037.624.37
Equity Securities Fv Ni 0.030.030.030.040.050.050.010.010.012.612.25NANANANANANANANANANA
Available For Sale Securities Debt Securities 0.560.580.520.450.480.440.390.440.52475.26536.07551.00569.29593.58490.97504.22512.83NA359.37367.51379.09

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Property Plant And Equipment Net 0.050.040.030.030.020.020.020.020.0216.2416.8015.8013.8712.1311.4611.819.697.096.083.863.36
Intangible Assets Net Excluding Goodwill 0.020.020.020.020.020.020.020.020.0215.1614.6414.4214.0313.5212.7411.9711.6811.1511.0410.8710.89
Other Assets Noncurrent 0.000.000.000.000.030.000.010.000.018.799.190.3110.1910.7311.270.310.310.270.270.210.10
Equity Securities Fv Ni 0.030.030.030.040.050.050.010.010.012.612.25NANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Liabilities Current 0.090.080.060.070.040.050.100.120.0766.4565.9266.5664.3163.7173.3253.8552.03101.34100.33107.43106.88
Accounts Payable Current 0.010.020.010.010.010.010.010.010.0110.5110.3110.198.308.995.493.805.986.876.607.384.28
Taxes Payable Current 0.00NANANANANANANANANANANANANANANANA0.16NA0.460.17
Accrued Liabilities Current 0.020.020.010.020.020.020.010.020.019.167.298.997.836.235.719.665.675.484.643.986.50
Contract With Customer Liability Current 0.040.040.040.040.010.020.080.090.0444.6946.1845.2045.5845.4859.2440.0840.0860.12NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Operating Lease Liability Noncurrent 0.020.030.030.030.030.000.010.010.017.638.048.569.089.6510.22NANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Stockholders Equity 0.720.740.760.730.620.650.580.570.57570.64593.00593.20610.24608.09609.57521.68532.27282.05290.54301.37303.75
Common Stock Value 0.000.000.000.000.000.000.000.000.000.570.570.570.570.560.560.560.560.470.470.470.47
Additional Paid In Capital 1.061.041.031.020.970.960.950.940.92908.08895.86887.87877.72865.16851.89845.37839.13570.67566.61562.02557.47
Retained Earnings Accumulated Deficit -0.33-0.29-0.26-0.28-0.36-0.32-0.37-0.37-0.35-339.49-304.48-296.40-269.49-259.27-243.23-323.28-305.08-287.29-275.44-259.88-253.00
Accumulated Other Comprehensive Income Loss Net Of Tax -0.01-0.01-0.01-0.00-0.00-0.000.000.000.001.481.061.161.441.630.34-0.97-2.34-1.81-1.10-1.24-1.20
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.010.010.01NA0.010.010.01NA0.018.236.51NA9.519.305.865.086.123.443.603.453.16

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Operating Activities -0.000.040.010.06-0.04-0.01-0.030.0218.20-27.689.46-19.58-6.48109.16-18.73-16.78-10.31-6.67-3.51-12.96-10.55
Net Cash Provided By Used In Investing Activities 0.00-0.08-0.070.01-0.04-0.050.040.08-71.9559.4112.5615.7322.06-102.4313.676.875.868.944.939.538.55
Net Cash Provided By Used In Financing Activities 0.000.000.000.030.000.000.010.01-5.464.001.472.973.053.970.671.174.150.620.991.101.03

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Operating Activities -0.000.040.010.06-0.04-0.01-0.030.0218.20-27.689.46-19.58-6.48109.16-18.73-16.78-10.31-6.67-3.51-12.96-10.55
Net Income Loss -0.03-0.030.020.07-0.040.05-0.00-0.01-0.01-35.02-8.07-26.91-10.22-16.0380.05-18.203.15-11.84-15.56-6.88-14.63
Profit Loss -0.03-0.030.020.07-0.040.05-0.00-0.0143.04-35.02-8.07-26.91-10.22-16.0380.05-18.203.15-11.84-15.56-6.04-15.47
Depreciation Depletion And Amortization 0.000.000.000.000.000.000.000.00-2.811.441.371.231.071.011.000.880.820.610.560.450.41
Increase Decrease In Accounts Payable -0.000.00-0.000.000.00-0.00-0.00-0.00-0.320.200.121.88-0.693.511.69-2.191.070.27-0.783.100.40
Share Based Compensation 0.010.010.010.010.010.010.010.010.010.016.517.189.519.305.865.086.123.443.603.453.16

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Investing Activities 0.00-0.08-0.070.01-0.04-0.050.040.08-71.9559.4112.5615.7322.06-102.4313.676.875.868.944.939.538.55
Payments To Acquire Property Plant And Equipment 0.010.010.000.010.000.000.000.00-2.690.622.072.912.581.450.412.791.011.482.580.760.49

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Financing Activities 0.000.000.000.030.000.000.010.01-5.464.001.472.973.053.970.671.174.150.620.991.101.03

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Revenues 0.030.030.090.150.020.070.030.040.0413.0932.383.5221.7619.48111.9411.5629.0430.150.0012.503.50
Alexion Pharmaceuticals Inc 0.000.000.000.000.000.000.000.000.003.803.302.505.405.10NA11.009.00NANANANA
Astellas 0.000.000.00NANANANA0.00-0.900.700.300.200.0013.80NANANANANANANA
Janssen 0.000.000.000.000.000.000.00NANANANANANANANANANANANANANA
Morpho Sys 0.000.000.000.000.000.000.000.000.000.0012.50NANANANANANANANANANA
Vir Biotechnology 0.000.000.000.000.000.00NA0.00-0.300.30NA-0.700.70NANANANANANANANA
Royalty 0.000.000.000.000.000.000.000.000.003.803.302.501.401.10NANANANANANANA
Collaboration 0.000.000.000.000.000.000.000.000.001.501.001.100.6014.400.300.1020.00NANANANA
Milestone 0.000.000.000.000.000.000.000.000.000.3012.50-0.1019.304.00NA11.509.00NANANANA
Revenue From Contract With Customer Excluding Assessed Tax 0.030.030.090.150.020.070.030.040.0413.0932.383.5221.7619.48111.9411.5629.0430.150.0012.503.50
Alexion Pharmaceuticals Inc 0.000.000.000.000.000.000.000.000.003.803.302.505.405.10NA11.009.00NANANANA
Astellas 0.000.000.00NANANANA0.00-0.900.700.300.200.0013.80NANANANANANANA
Janssen 0.000.000.000.000.000.000.00NANANANANANANANANANANANANANA
Morpho Sys 0.000.000.000.000.000.000.000.000.000.0012.50NANANANANANANANANANA
Vir Biotechnology 0.000.000.000.000.000.00NA0.00-0.300.30NA-0.700.70NANANANANANANANA
Royalty 0.000.000.000.000.000.000.000.000.003.803.302.501.401.10NANANANANANANA
Collaboration 0.000.000.000.000.000.000.000.000.001.501.001.100.6014.400.300.1020.00NANANANA
Milestone 0.000.000.000.000.000.000.000.000.000.3012.50-0.1019.304.00NA11.509.00NANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Other Nonoperating Income Expense
Balance Sheet
Intangible Assets Net Excluding Goodwill
Assets
Intangible Assets Net Excluding Goodwill
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
Liabilities
Operating Lease Liability
Current Liabilities
Taxes Payable Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Other Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Counterparty Name
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:CounterpartyName
(None,)
Revenuesus-gaap: Counterparty Name
us-gaap:ComprehensiveIncomeNetOfTax
us-gaap:StatementEquityComponents
(None,)
Comprehensive Income Net Of Taxus-gaap: Statement Equity Components
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:CashAndCashEquivalentsAtCarryingValue
us-gaap:InvestmentType
(None,)
Cash And Cash Equivalents At Carrying Valueus-gaap: Investment Type
us-gaap:EquitySecuritiesFvNi
us-gaap:CounterpartyName, us-gaap:StatementClassOfStock
(None, 'us-gaap:CommonStock')
Equity Securities Fv Nius-gaap: Counterparty Name, us-gaap: Statement Class Of Stock
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:InvestmentType
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:InvestmentType
('us-gaap:FairValueInputsLevel2', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel2', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:CounterpartyName, us-gaap:StatementClassOfStock
(None, 'us-gaap:CommonStock')
Equity Securities Fv Nius-gaap: Counterparty Name, us-gaap: Statement Class Of Stock
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:ShareBasedCompensation
us-gaap:IncomeStatementLocation
(None,)
Share Based Compensationus-gaap: Income Statement Location
us-gaap:ShareBasedCompensation
us-gaap:AwardType
(None,)
Share Based Compensationus-gaap: Award Type
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:CounterpartyName
(None,)
Revenuesus-gaap: Counterparty Name
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Counterparty Name